GMED Globus Medical, Inc.

bearish track record → $93.83 -2.99 (-3.1%)
Get emailed when GMED changes direction
Mkt Cap $13B P/E 24.7 fwd 19.5 52wk $51.79 - $101.40 Earnings 2026-05-07 46d ago
Insider selling: $47,219,245 sold by 10 insiders (30d)
Est. revisions: +0.0% (6 up, 5 down in 30d)
Backed by structured data (insider trades, analyst ratings, or filings)
Factor Model (net +0.2)

Factor Model

net +0.2 1.0 / 10
Est. Revisions
+0.0
Insider Activity
+0.0
Momentum
+0.0
Analyst Rev.
+0.2
Narrative Gap
+0.0

Acquisition Woes and Robotics Weakness Weigh on Valuation

Watch: Monitor next earnings call for acquisition synergy timelines and robotics segment stabilization. If supply chain pressures ease and robotics margins trend positive, the discount could tighten. Failure to show progress on either front risks further downside.

Globus Medical is grappling with integration challenges from recent acquisitions, supply chain headwinds, and softness in its robotics segment. The stock closed at $90.46 on March 4, 2026, down from its 52-week high of $101.40. Despite operational friction, Invesco identifies the company as trading at a meaningful discount to intrinsic value — though that discount may reflect legitimate concerns rather than pure mispricing.

The combination of acquisition execution risk, supply chain disruption, and a struggling robotics business suggests operational headwinds are real, not transient. A valuation discount rarely exists without reason. Until management demonstrates progress on integration and robotics recovery, the stock lacks a clear catalyst to re-rate higher.

Evidence

9d ago Insider sell by SCAVILLA DANIEL T (GMED): $11,050,000
26d ago Macquarie Initiates Coverage of Okta (OKTA) with an Outperform Rating yahoo-finance
48d ago Globus Medical (GMED) Slips on Acquisition and Robotics Segment Challenges yahoo-finance
Fundamentals & Data ▾
Globus Medical, Inc. Healthcare · Medical Devices
Mkt Cap
$13B
P/E
24.7 fwd 19.5
Beta
1.09
52w Range
$51.79 - $101.40
Short Interest
2.8M 2.3%
Days to Cover
2.9 -13%
Technicals downtrend
from 52w Hi
-3.1%
1w return
-1.2%
Insiders
selling 0B / 13S
EPS Estimate
$0.92 +0.0% 30d 6up / 5dn
Est. Dispersion
28% 14 analysts
Analyst Target
$110 $90 - $123
Options P/C
0.09
Insider Cluster
strong sell 0B / 8S
Financials
Revenue
$826M +26% YoY
FCF
$202M
Gross Margin
68%
Op Margin
22%
Momentum: accelerating
Recent Filings & Data
insider trade 45
net selling · $47,219,245 sold
10 insiders · 45 transactions (30d)
Recent transactions
HULLER KELLY GRACE · sell · $1,890,000
HULLER KELLY GRACE · exercise · $871,600
HULLER KELLY GRACE · sell · $876,700
HULLER KELLY GRACE · exercise · $456,400
NORWALK LESLIE V · sell · $202,200
KLINE KYLE · sell · $363,353
KLINE KYLE · exercise · $186,421
NORWALK LESLIE V · sell · $355,400
PAUL DAVID C · exercise · $877,250
KLINE KYLE · sell · $1,668,780
KLINE KYLE · exercise · $1,109,876
HULLER KELLY GRACE · sell · $675,000
HULLER KELLY GRACE · exercise · $194,700
DAVIDAR DAVID D · sell · $2,150,005
DAVIDAR DAVID D · exercise · $638,000
ZARRILLI STEPHEN T · sell · $2,107,258
ZARRILLI STEPHEN T · exercise · $1,103,500
RHOADS ANN D · sell · $818,000
RHOADS ANN D · sell · $584,600
RHOADS ANN D · sell · $590,100
PFEIL KEITH W. · sell · $1,250,770
PFEIL KEITH W. · exercise · $733,561
DAVIDAR DAVID D · other
HULLER KELLY GRACE · sell · $217,502
HULLER KELLY GRACE · exercise · $60,525
LEMAITRE DANIEL · sell · $1,221,893
LEMAITRE DANIEL · exercise · $935,094
DAVIDAR DAVID D · sell · $3,400,050
SCAVILLA DANIEL T · sell · $11,050,000
SCAVILLA DANIEL T · exercise · $5,674,900
PAUL DAVID C · exercise · $627,612
SCAVILLA DANIEL T · sell · $4,801,200
SCAVILLA DANIEL T · exercise · $2,101,200
HULLER KELLY GRACE · sell · $405,050
HULLER KELLY GRACE · exercise · $121,050
DAVIDAR DAVID D · sell · $3,751,813
HULLER KELLY GRACE · sell · $562,649
HULLER KELLY GRACE · exercise · $193,500
RHOADS ANN D · sell · $1,055,400
RHOADS ANN D · exercise · $871,900
DAVIDAR DAVID D · sell · $1,761,500
NORWALK LESLIE V · sell · $70,000
LEMAITRE DANIEL · sell · $4,090,022
LEMAITRE DANIEL · exercise · $2,460,850
DAVIDAR DAVID D · sell · $1,300,000
3 signals · latest 9d ago

Get alerted when GMED changes direction

We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.

All stocks → Our calls → How it works →